For the Inventor, By the Inventor

Enter assignee name

Biontech Rna Pharmaceuticals Gmbh

USPTO Granted Patents = 17

CIPO Patents = 2

EPO Patents = 21

Trademarks = 7

Forward Citations = 79

Loading Chart...

Loading Chart...

56 inventors (with patents filed for the assignee):

Ugur Sahin (14 out of 182 patents)

Sebastian Kreiter (6 out of 23 patents)

Mustafa Diken (6 out of 17 patents)

4. Heinrich Haas (4 out of 20 patents)

5. Yves Hüsemann (3 out of 5 patents)

6. Tim Beissert (3 out of 11 patents)

7. Marco Alexander Poleganov (3 out of 6 patents)

8. Hossam Hefesha (2 out of 4 patents)

9. Jan Diekmann (2 out of 4 patents)

10. Friederike Gieseke (2 out of 16 patents)

11. Stephanie Herz (2 out of 2 patents)

12. Lars Koste (2 out of 2 patents)

13. Andreas Kuhn (2 out of 9 patents)

14. Kerstin Reuter (2 out of 5 patents)

15. Claudia Paret (2 out of 6 patents)

17 patents: Sort by Forward Citations

1. 12291717 - RNA replicon for reprogramming somatic cells (2025-05-06),

2. 12281138 - 5'-cap-trinucleotide- or higher oligonucleotide compounds and their use in stabilizing RNA, expressing proteins in therapy (2025-04-21),

3. 11173120 - Stable formulations of lipids and liposomes (2021-11-16),

4. 11045418 - Lipid particle formulations for delivery of RNA and water-soluble therapeutically effective compounds to a target cell (2021-06-29),

5. 11020477 - RNA vaccines (2021-06-01),

6. 10987413 - MHC-independent tumor-associated antigens (2021-04-27),

7. 10808242 - Method for reducing immunogenicity of RNA (2020-10-20),

8. 10808019 - Nucleic acid molecules encoding cytokine fusion proteins comprising tumor necrosis factor (TNF) superfamily ligands (2020-10-20),

9. 10738355 - Individualized vaccines for cancer (2020-08-11),

10. 10729784 - Method for cellular RNA expression (2020-08-04),

11. 10717982 - Stabilization of poly(A) sequence encoding DNA sequences (2020-07-21),

12. 10669322 - RNA molecules encoding cytokine fusion proteins and methods of use thereof (2020-06-02),

13. 10576146 - Particles comprising a shell with RNA (2020-03-03),

14. 10429392 - Methods and compositions for diagnosis and treatment of cancer (2019-10-01),

15. 10207009 - Method for cellular RNA expression (2019-02-19),

BioNTech RNA Pharmaceuticals GmbH is a leading biotechnology company focused on developing innovative immunotherapies for cancer and infectious diseases. Utilizing its mRNA technology platform, BioNTech is working to harness the power of the body's immune system to fight disease. The company's pipeline includes potential treatments for a variety of cancers and infectious diseases, with a mission to revolutionize the way diseases are treated and cured.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

17 Patents

#15 in Mainz

#2,507 in Germany

#34,858 in the World

Biontech Rna Pharmaceuticals Gmbh

Forward Citations = 79

56 inventors:

Ugur Sahin (14 out of 182 patents)

Sebastian Kreiter (6 out of 23 patents)

Mustafa Diken (6 out of 17 patents)

4. Heinrich Haas (4 out of 20 patents)

5. Yves Hüsemann (3 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…